Related Posts

• 
  Critical Path for Parkinson’s 3DT initiative: Early regulatory engagement to optimize paths for efficient use of digital health technologies in PD clinical trials
• 
  Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration
• 
  Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan
• 
  Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA
• 
  Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA